PASAY CITY – The Philippine Council for Health Research and Development (PCHRD) held a Research to Policy Process Forum last 17 March 2017 at the Philippine International Convention Center, Pasay City focusing on the process of and challenges in creating research-based policies for the Filipino community.
Dr. Gloria Nenita Velasco, Medical Officer IV of the Department of Health – Health Policy Development and Planning Bureau, talked about the current challenges and possible solutions to increase research to policy turn-out in the country. In her talk, she cited 1) limited research production due to poor data collection and limited funds, 2) low research credibility due to poor evidence, and 3) limited appreciation of research to policy impacts as challenges affecting research uptake. Dr. Velasco also suggested that health priorities should be policy-driven to ensure that health researches will be utilized by the people through policy implementation. Research co-production and increased support for evidence-based researches were also cited as strategies to effectively turn research into concrete policies.
The process of transforming research into a policy document was also discussed in the forum. Apart from data and findings, Dr. Fely Marilyn E. Lorenzo, former Professor of the Department of Health Policy and Administration – University of the Philippines Manila said that policy documents must be able to capture the views and wishes of the beneficiaries, opinions of the researchers, and testimonials, as well. An effective policy research must be problem-driven, multi-dimensional, flexible, and strongly evidence-based, she cited. On the issue of policy adoption as a major challenge in implementing research-based policies, “It’s always prudent to consult with stakeholders/end-users,” says Dr. Lorenzo.
The Research to Policy Forum was part of the PCHRD 35th Anniversary Celebration attended by health researchers and stakeholders nationwide.
The UK Medical Research Council (MRC), and the Department of Science and Technology (DOST) through the Philippine Council for Health and Research Development (PCHRD) invite concept proposals to the second UK-Philippines Joint Health Research Call.
This initiative will provide funding for high quality 3-year collaborative research projects focusing on Communicable and Non-Communicable Diseases of relevance to the Philippines. This exciting initiative builds on the MRC-PCHRD Call launched in 2015 through which 6 proposals addressing research needs in Infectious Diseases were funded.
The second call being launched by MRC and PCHRD aims to further build on the strengths of the UK and Filipino research base by funding innovative partnerships in Communicable as well as Non-Communicable Diseases of relevance to the Philippines. While the 2015 call focused entirely on Infectious Disease research, this second call aims to enable opportunities for partnership in the areas of Infectious Diseases, and Type 2 Diabetes Mellitus (T2DM).
Based on the latest Philippine health statistics, the NCD burden in the Philippines has been steadily increasing over the last decade. NCDs are now the leading cause of morbidity in the country, and mortality rates have been steadily rising in the last 35 years, with the greatest increases noted within the last two decades. In particular, the mortality trend from T2DM in the Philippines has been rising steadily, with 14.1, 25.5, and 27.2 deaths per 100,000 population in 2000, 2008, and 2013 respectively, as shown in Philippine Health Statistics data. The 2008 Philippine National Nutrition Survey also reported that prevalence rates for DM type 2 increased progressively from age 30 years and peaked among the age groups 50-59 and 60-69 years. The joint funders hope that collaborations between UK and Filipino researchers will increase capability for understanding and tackling the growing burden of T2DM.
Objectives and scope
1. Communicable diseases of relevance to the Philippines, particularly on diseases that impact the most vulnerable in society, specifically:
Chronic respiratory infections including Pneumonia
Areas of particular research interest within the infectious disease space include but are not limited to:
Genomics and molecular technologies: for novel biomarker identification, with a focus on host and pathogen ‘omics and host-pathogen interactions
Diagnostics: Development of cost effective, rapid diagnostic tools, utilizing off-patent/ lapsed and/or novel technologies. Specific topics include the following:
Point of care
Diagnostic test done at the time and place of patient care
Screening / confirmatory /prognostic
Screening to detect early disease or risk factors for disease
Confirming the presence or absence of disease
Prognosticating and to predicting the likely outcome of disease, susceptibility and chances of recovery
Information and Communication Technology (ICT)/e-health: Development of user-friendly ICT solutions to accelerate the gathering and processing of health and related information for policymaking, and delivery of quality healthcare services
2. Non- Communicable Diseases (NCDs), specifically; Type 2 Diabetes Mellitus
Areas of particular research interest include but are not limited to:
Use of animal models in identifying the genes responsible for development of or protection from the disease
Studies on creation/ use of animal models for therapeutic trials
Development of cost-effective biomedical devices for diagnosing, treatment, and/or management T2DM among Filipinos
The total funding available for this call is as follows:
MRC - up to £2 million pounds (Funding provided to the successful UK applicants)
PCHRD – up to £1.25 million pounds/ Php 80 million Pesos (Funding provided to the successful Filipino applicants)
Up to £650 thousand pounds will be available per partnership (up to£400K from UK and up to £250K/ Php 16 million Pesos from Philippines) to support activities for up to 3 years.
It is expected that this funding will support around 6 joint projects; up to 4 in Infectious Diseases and up to 2 in Diabetes Mellitus.
Applications will be required to have one UK Principal Investigator and one Filipino Principal Investigator. If appropriate, applications with industrial partners are welcomed (although no funding will be available to these partners).
Assessment Process and decision making process
To be funded, proposals must be internationally competitive and at a standard equivalent to that normally expected to be supported by each funding organisation.
Significance and potential impact of the research
Scientific Rationale: novelty, importance and timeliness of the research
Design and feasibility of the Project Plan
Partnership: including strength and clarity of collaborations and opportunities provided, quality of the project management structure proposed
Quality and suitability of the research environment and of the facilities
Value for money for Filipino and UK science
Ethical considerations and governance arrangements
In addition, applicants must describe how the proposed UK funded work is ODA compliant (approximately 150 words). This section will be made publicly available. For further information on ODA, please visit: http://www.newtonfund.ac.uk/about/what-is-oda/
Researchers with successful concept proposals will be invited to submit a full proposal. To enhance the quality of the partnership and support the development of high quality full stage proposals, MRC and PCHRD will be making travel grants (up to £3K) available for full proposal development. Only applicants from the shortlisted concept proposals will be invited to submit full proposals in October 2017.
Funding decision process for this Call will be the following:
The Philippine Council for Health Research and Development (PCHRD) will celebrate its 35th year anniversary on 17 March 2017 at the Philippine International Convention Center, Pasay City.
With the theme, “Health Innovations: Translating Science to Benefit,” the anniversary will feature talks from translational medicine experts and stakeholders, specifically on the role of the health research community in cultivating an enabling environment for research translation. Current trends, issues, and challenges in the field will also be taken up in the discussions.
Part of the program is recognizing DOST-PCHRD’s longstanding partnership with Gruppo Medica, Inc., that led to the creation of the DOST-PCHRD – Gruppo Medica Award for Outstanding Undergraduate Thesis in Herbal Medicine. The award was granted to motivate students to view research as an opportunity to contribute to the national health agenda while they develop their careers in research.
During the anniversary celebration, the Philippine Health Research Ethics Board will also be awarding newly-accredited Research Ethics Committees that are expected to uphold the highest standards of ethics in health research.
The Clinical Research Fellowship Program for Hepatology will also be launched during the event. The program is a partnership among DOST-PCHRD, Hepatology Society of the Philippines, Inc., and Fondazione Italiano Fegato, an Italy-based heath institution dedicated to liver studies.
“The research process does not end with project completion. Research results must be translated into quantifiable outputs and must be able to reach its target beneficiaries,” said Dr. Jaime C. Montoya, DOST-PCHRD Executive Director.
Health researchers and policymakers nationwide are expected to grace the celebration. DOST-PCHRD hopes to foster local and international partnerships and provide an opportunity to present existing research products and services to a wider set of intended users and contribute to national health goals.
PASAY CITY, Metro Manila- “The presence of health research in the regions is now more evident,” thus emphasized by Executive Director Jaime Montoya in the recent celebration of the 35th anniversary of the Philippine Council for Health Research and Development (PCHRD) on 17 March 2017 at the Philippine International Convention Center.
According to Dr. Montoya, the event is more than an anniversary but a celebration of the commitment and dedication of the Council to carry out programs which enhance research productivity. He then cited various accomplishments of the Council including the 10 Tuklas Lunas Development Centers established in seven regions, 1000 RxBox devices to be deployed to 1,000 health centers across the country, and expansion of eHATID project to HATID ASEAN (Health Technologies for Informed Decision making in the Association of South East Asian Nations).
Responding to the impact of disasters and climate change on health in the country, the Council also added Disaster Risk Reduction and Climate Change Adaptation for Health (DRR-CCA Health) as new priority area for research. As the secretariat of the Philippine Health Research Ethics Board (PHREB), PCHRD accredited 48 research ethics committees.
Dr. Montoya also shared that the Council will disseminate the PNHRS Guidelines for Health Research Prioritization to research institutions across the country. “It is with great hope that through this document, our research institutions and regional research consortia will be more empowered in terms of preparation, implementation, and post-implementation of their research agenda,” he added.
Discussing the celebration’s theme, Dr. Montoya emphasized that research process does not end with project completion alone but should be translated into quantifiable outputs that empower beneficiaries to take care of their health.
“The accomplishments of PCHRD are the results of the hard work of its dedicated people and committed partners,” Dr. Montoya said as he urged the people and partners of the Council to continue giving their best and working with greater passion.
The International Prize for Biology was established in 1985 to commemorate the sixty-year reign of Emperor Showa and his long devotion to biological research. It also pays tribute to the present Emperor, His Majesty, Emperor Akihito, who has labored for many years to advance the taxonomical study of gobioid fish, while striving continuously to elevate the international stature of the Prize.
Each year, the International Prize for Biology is conferred upon a distinguished researcher in a field selected by the Prize Committee from among all the fields of biology. Based on nominations gathered from around the world, the Prize is awarded to a biologist judged to have a superlative record of achievements in the subject field. Once every decade, “systematic biology and taxonomy” is selected for the Prize as it is the field in which, like Emperor Showa before him, His Majesty the present Emperor has conducted research over many years.
So as to spread global recognition of the International Prize for Biology as a tribute to excellent achievement while accelerating the advancement of biology, the Prize Committee asks for your sustained cooperation and support.
Deadline: April 21, 2017
For more information and to download the nomination form, visit: http://www.jsps.go.jp/english/e-biol/index.html